• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Two Analysts Increase Price Target for Aphria Inc.

January 11, 2018


Two different firms have recently updated their buy ratings for shares of Aphria Inc. (TSX:APH) (OTC:APHQF) (FRA:10E) closely following the company's announcement that it has entered a strategic relationship with Double Diamond Farms to provide an additional 120,000 kgs of annual cannabis production, as well as the company's announcement that it increased revenues by 39%


The analysts' 12-month price targets both provide tremendous upside potential for shares of Aphria, so we wanted to fill in existing and prospective investors on the price targets and the theses behind them. 


Canaccord Genuity


Matt Bottomley, the Alternative Pharmaceuticals Research Analyst at Canaccord Genuity reiterated his buy rating on shares of Aphria. Bottomley' price target for the stock is $23.00 CAD per share, equivalent to roughly $18.36 USD. At the time of writing this, shares of Aphria on the TSX were trading at $20.94 CAD per share, representing over 9.8% upside potential. 



Bottomey's $23 CAD price target is just north of the average analyst price target of $19.42, according to TipRanks. With that said, the $23 CAD price target is below the price target from Noel Atkinson at Clarus.


Clarus Securities


Noel Atkinson, CFA, the Vice President of Equity Research at Clarus Securities, also reiterated his buy rating on shares of Aphria. Atkinson's price target for the stock is $25.25 CAD per share, equivalent to roughly $20.13 USD. At the time of writing this, shares of Aphria on the TSX were trading at $20.94 per share, representing over 20% potential upside.


Atkinson stated


“We have increased our CY19 and FY20 (May) estimates as a result of the higher capacity outlook, and we expect the minority interest offset in Adj. EBITDA to be relatively modest. Our price target rises to C$25.25 per share (was C$23.25) or 20x CY2019 (12 months ending February 2020) EV/Adj. EBITDA. We maintain our Buy rating but caution of high intra- day and inter-day share price volatility being seen across the cannabis LP sector."


This is the highest price target out of the three analysts covering the company. 


For more Canadian Licensed Producer stocks, check out our Canadian LP stock database. Be sure to subscribe to one or more of our free newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, and Instagram



Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.